|
Apr 11
|
Do You Believe in the Upside Trajectory of Lifecore Biomedical (LFCR)?
|
|
Apr 1
|
Lifecore Biomedical Provides Business Update Outlining Fiscal 2024 Outlook and Year-to-date Progress
|
|
Mar 26
|
Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update
|
|
Mar 21
|
Lifecore (LFCR) Down 30% on Ending Strategic Review With No Deal
|
|
Mar 20
|
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
|
|
Mar 20
|
Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023
|
|
Jan 30
|
Should You Hold Lifecore Biomedical (LFCR) for Long Term?
|
|
Jan 12
|
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
|
|
Jan 10
|
Even after rising 12% this past week, Lifecore Biomedical (NASDAQ:LFCR) shareholders are still down 39% over the past five years
|
|
Nov 20
|
Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods
|
|
Nov 17
|
Lifecore Biomedical Avoids U.S. Prosecution Over Alleged Mexico Bribes
|
|
Jul 7
|
QGEN vs. LFCR: Which Stock Is the Better Value Option?
|